Edge Wealth Management’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-100
Closed -$1K 682
2020
Q2
$1K Hold
100
﹤0.01% 661
2020
Q1
$1K Hold
100
﹤0.01% 618
2019
Q4
$1K Hold
100
﹤0.01% 583
2019
Q3
$1K Buy
+100
New +$1K ﹤0.01% 586
2019
Q2
Sell
-100
Closed 651
2019
Q1
$0 Hold
100
﹤0.01% 636
2018
Q4
$0 Hold
100
﹤0.01% 656
2018
Q3
$1K Buy
+100
New +$1K ﹤0.01% 603
2018
Q1
Sell
-100
Closed -$1K 591
2017
Q4
$1K Hold
100
﹤0.01% 530
2017
Q3
$1K Hold
100
﹤0.01% 525
2017
Q2
$1K Hold
100
﹤0.01% 525
2017
Q1
$1K Hold
100
﹤0.01% 507
2016
Q4
$1K Buy
+100
New +$1K ﹤0.01% 482
2016
Q2
Sell
-100
Closed -$1K 511
2016
Q1
$1K Hold
100
﹤0.01% 447
2015
Q4
$1K Hold
100
﹤0.01% 456
2015
Q3
$1K Hold
100
﹤0.01% 458
2015
Q2
$0 Hold
100
﹤0.01% 469
2015
Q1
$1K Buy
+100
New +$234 ﹤0.01% 444
2014
Q2
Sell
-2,100
Closed -$6K 444
2014
Q1
$6K Sell
2,100
-1,000
-32% -$3.29K ﹤0.01% 320
2013
Q4
$10K Buy
3,100
+3,000
+3,000% +$8.37K ﹤0.01% 273
2013
Q3
$0 Hold
100
﹤0.01% 372
2013
Q2
$0 Buy
+100
New +$524 ﹤0.01% 332

Edge Wealth Management's ECTE Position: Q3 2020 in Review

Edge Wealth Management sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2020, closing a stake of 100 shares — an estimated $1K sold.

Edge Wealth Management first reported a position in ECTE in Q2 2013 and held it in 21 quarters. The position peaked at $10K in Q4 2013. 0 funds tracked by Wall St. Rank hold ECTE as of Q3 2020.

  • Edge Wealth Management reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2020 after selling out during the quarter.
  • Edge Wealth Management sold 100 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2020, an estimated $1K.
  • Edge Wealth Management first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 21 quarters.
  • Edge Wealth Management's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $10K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2020.

Based on Edge Wealth Management's 13F filing for Q3 2020, filed 21 Oct 2020.